Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
2.370
-0.030 (-1.25%)
Nov 4, 2024, 4:00 PM EST - Market closed
Harvard Bioscience Employees
As of December 31, 2023, Harvard Bioscience had 416 total employees, including 391 full-time and 25 part-time employees. The number of employees decreased by 39 or -8.57% compared to the previous year.
Employees
416
Change (1Y)
-39
Growth (1Y)
-8.57%
Revenue / Employee
$243,089
Profits / Employee
-$25,668
Market Cap
103.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
FONAR | 561 |
EDAP TMS | 307 |
Century Therapeutics | 165 |
Adicet Bio | 143 |
OptiNose | 132 |
BioAtla | 65 |
Relmada Therapeutics | 20 |
Genenta Science | 14 |
HBIO News
- 6 days ago - Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - GlobeNewsWire
- 6 weeks ago - Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - GlobeNewsWire
- 2 months ago - Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference - GlobeNewsWire
- 3 months ago - Harvard Bioscience, Inc. (HBIO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Harvard Bioscience Announces Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET - GlobeNewsWire
- 5 months ago - Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 - GlobeNewsWire
- 5 months ago - Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - GlobeNewsWire